Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02898688 · ClinicalTrials.gov registry record · NA

P3+ Intervention Phase

A NA study of Vaccination, sponsored by Emory University.

Completed
Registry status
NA
Development phase
2,200
Enrollment target
20
Study locations

NCT02898688 is a NA study of Vaccination that has completed, run by Emory University. The registered enrollment target is 2,200 participants, below the 10,050-participant average among 12 other Vaccination trials with a reported enrollment target (78% lower). The trial reports 20 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02898688, a NA study of Vaccination, has completed, sponsored by Emory University.

COMPLETED
Registry status
NA
Development phase
2,200 participants
Enrollment target
20
Study locations

Study Summary

This study will address vaccine uptake both for pregnant women and for their children, through 20 months of age, to test the hypothesis that exposure to the P3+ intervention package will increase the likelihood a pregnant woman gets herself vaccinated against influenza and pertussis before delivery and get her child vaccinated on time. This study builds off of a prior intervention, developed by Emory, at the practice, provider, and patient levels (P3) to develop, implement and evaluate an enhanced intervention (P3+) to improve vaccination uptake among pregnant women, and later, their children.

Conditions Studied

Vaccination

Interventions

  • BEHAVIORAL Control Site
  • BEHAVIORAL Intervention Site
  • BEHAVIORAL Patient-level Control Group
  • BEHAVIORAL Patient-level Intervention Group

Study Locations (20)

Colorado

  • CU Center for Midwifery - Aurora
  • CU Maternal and Fetal Medicine Clinic - Aurora
  • University Nurse Midwives - Aurora
  • Boulder Women's Care - Boulder
  • St. Joe's Midwives - Denver
  • Partners in Women's Health at Rose - Denver
  • Rocky Mountain OBGYN - Denver
  • Colorado Mountain Medical - Edwards
  • Bella Natural Women's Care - Englewood
  • Associates in Women's Health - Golden
  • Women's Health Group Thornton - Thornton

Georgia

  • Atlanta Women's Specialists - Alpharetta
  • Roswell Ob/Gyn - Alpharetta
  • Athens Midwifery - Athens
  • Athens Ob-Gyn - Athens
  • Women's Healthcare Associates of Athens - Athens
  • Emory Clinic - Atlanta
  • Riverbend OB/GYN and Counseling - Atlanta
  • Peachtree Women's Clinic - Cumming
  • Comprehensive Women's OB/GYN - Duluth

Trial Details

FieldValue
Enrollment Target 2,200 participants
Start Date 2017-06-12
Est. Completion 2020-07-06
Phase NA

Sponsor

Emory University

1,208 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02898688

The ClinicalTrials.gov registry entry for NCT02898688 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 10,050-participant average among 12 other Vaccination trials with a reported enrollment target (78% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Vaccination appearing as the primary indexed condition, and to 4 interventions - of which Control Site is the first listed.

NCT02898688 reports 20 study locations spanning 2 distinct geographic areas - top geographies include Colorado, Georgia.

Frequently Asked Questions

What is clinical trial NCT02898688 about?

NCT02898688 is a clinical study titled "P3+ Intervention Phase". This study will address vaccine uptake both for pregnant women and for their children, through 20 months of age, to test the hypothesis that exposure to the P3+ intervention package will increase the likelihood a pregnant woman gets herself vaccinated against influenza and pertussis before delivery ...

What is the current status of trial NCT02898688?

This trial is currently completed. It is a NA study. The enrollment target is 2,200 participants. The study started on 2017-06-12. Estimated completion is 2020-07-06.

What conditions does trial NCT02898688 study?

This clinical trial studies the following conditions: Vaccination.

What interventions are being tested in trial NCT02898688?

The interventions under investigation include: Control Site (BEHAVIORAL), Intervention Site (BEHAVIORAL), Patient-level Control Group (BEHAVIORAL), Patient-level Intervention Group (BEHAVIORAL).

Who is sponsoring clinical trial NCT02898688?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02898688 being conducted?

This trial has 20 study locations across Colorado, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Vaccination

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Vaccination

All registered trials for this condition

Colorado

All trials with a study site in Colorado

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.